Lincoln Pharmaceuticals Limited (BSE: 531633)
Health Care · Pharmaceuticals · IN
Rs617.30
+0.73% today · +13.5% 1Y
Lincoln Pharmaceuticals Limited (BSE: 531633) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $129.23M.
Over the last twelve months the share price has gained 13.5%, trading between 439.95 and 770.00.
Tweenvest scores Lincoln Pharmaceuticals Limited across four factors: quality 83/100, value 52/100, growth 47/100, dividend 40/100. Its strongest factor is quality.
531633 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $129.23M
- Revenue (TTM)
- $73.43M
- P/E
- 12.82
- EPS
- 48.15
- Dividend yield
- 0.29%
- Beta (5Y)
- 0.39
- 52-week high
- Rs770.00
- 52-week low
- Rs439.95
- Avg volume (3M)
- —
- Shares outstanding
- 20.03M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.50 | -0.01% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.20 | +0.02% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.